Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 53.0 | 63 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 51.0 | 52 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 58.0 | 52 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 61.0 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 84.5 | 74 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 84.0 | 62 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 71.0 | 45 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 71.0 | 67 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 90.0 | 39 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | Eotaxin | 79.0 | 41 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 54.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 52.0 | 51 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 55.0 | 61 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 55.0 | 43 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 47.0 | 69 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 50.5 | 54 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 67.0 | 71 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 74.0 | 59 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 52.0 | 64 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 53.0 | 58 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 65.0 | 51 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | Eotaxin | 69.0 | 35 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | Eotaxin | 46.5 | 58 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | Eotaxin | 47.5 | 52 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | Eotaxin | 51.0 | 54 |